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Abstract 
 
Herein we report the successful design, construction and characterization of a 770 kb synthetic 
yeast chromosome II (synII). Our study incorporates characterization at multiple levels, 
including phenomics, transcriptomics, proteomics, chromosome segregation and replication 
analysis to provide a thorough and comprehensive analysis of a synthetic chromosome. Our 
“Trans-Omics” analyses reveal a modest but potentially significant pervasive up-regulation of 
translational machinery observed in synII is mainly caused by the deletion of 13 tRNAs. By 
both complementation assays and SCRaMbLE, we targeted and debuged the origin of a growth 
defect at 37°C in glycerol medium, which is related to misregulation of the HOG response. 
Despite the subtle differences, the synII strain shows highly consistent biological processes 
comparable to the native strain.  
 
One Sentence Summary:  
A near megabase synthetic chromosome, synII, was characterized using a “Trans-Omics” 
approach, which revealed a modest up-regulation of translational machinery; this was reversed 
by restoring the normal complement of tRNA genes to the strain. 
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Introduction 
 
Yeasts are among the most important eukaryotic microorganisms, both scientifically and 
economically, with at least 1500 species identified to date. In the past few decades, a number of 
different yeast species have been sequenced, and comprehensive genomic comparison studies 
have revealed answers to several complex evolutionary questions such as whole-genome 
duplication and horizontal gene transfer during their history (1-5). However, despite the 
increased knowledge and understanding of the natural genome, our ability to engineer the entire 
genetic material is still very limited. Rapidly developing DNA synthesis techniques have made 
a “build to understand” approach feasible, which allows synthetic biologists to re-engineer and 
construct genes, pathways and even entire genomes (6-12).  
 
Under the collaborative framework of the Sc2.0 project (www.syntheticyeast.org), we report 
the completion of yeast synthetic chromosome II, termed synII. The sequence of native 
Saccharomyces cerevisiae chromosome II was determined over two decades ago. This native 
chromosome is 807,888 bp in length and includes 410 open reading frames, 13 tRNAs, and 30 
introns(13). synII was designed based on the native chromosome II following previously 
reported rules (12, 14, 15), resulting in a “designer” chromosome 770,035 bp in length, 43,149 
bp shorter than the native sequence. synII was initially synthesized as minichunks (~3 kb), 
assembled into chunks (~10 kb) and integrated into the yeast genome to replace the native 
chromosome. Extensive Trans-Omics tests were conducted, including phenomics, 
transcriptomics, proteomics, chromosome segregation and replication analyses, which indicated 
that synII yeast, despite significant sequence alterations, is virtually indistinguishable from wild 
type. However, our analyses reveal that up-regulation of many components of the translational 
machinery (for example ribosomal proteins at both the RNA and protein levels) is a typical 
feature of synthetic chromosome replacement strains, and the main cause for this subtle defect 
was shown to be the reduction tRNA gene copy number; it was reversed by restoring the tRNA 
gene copy number.  
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Results  
 
Design and synthesis of synII 
Complete chromosome re-design of chromosome II was performed based on the Sc2.0 project 
standards (12) using the BioStudio design suite (14) to yield the synthetic yeast chromosome II 
(termed synII).  Relative to the wild-type reference sequence, synII has 33 deletions (53,605 bp 
in total), 269 insertions (10,456 bp in total) and 14,949 single nucleotide substitutions. While 
synII represents a 5.3% reduction in sheer size compared to the native chromosome II, but 
hundreds of designer features were encoded throughout this synthetic chromosome (table S1, 
and supplementary Materials and Methods). The extensive changes made to the 
chromosome naturally raise the question whether there are any subtle phenotypic effects 
that may have been missed by previous studies. 
 
Compared with previous synthetic strategies (12, 15), we devised an alternative modular 
assembly method for the construction of synII. This new approach enables parallel integration 
to speed assembly, while at the same time also providing an effective route to debug potential 
phenotypic defects (see below). We divided synII into 25 megachunks (~30 kb each) using 
BioStudio, and each megachunk was then segmented by an in-house software “Segman” into 
minichunks (~3 kb, fig. S1A), which are compatible with the Gibson assembly method (16) (fig. 
S1B) for construction into chunks (Detailed information on megachunks, chunks and 
minichunk can be found at www.syntheticyeast.org). Instead of performing step-by-step 
megachunk integration  (SwAP-In) (15) from one end (left or right arm), we performed 
integration in parallel from both ends with two separate parental strains YS000-L and YS000-R 
(fig. S1C) bearing synII-L and synII-R respectively, which overlap by 30 kb, effectively 
reducing the overall integration time by almost 50%. These two strains were crossed to produce 
a heterozygous diploid. Despite hundreds of modifications being introduced in synII, regions 
sharing substantial sequence similarity to the native chromosome remain. We anticipate that 
these might trigger various unwanted meiotic recombination events, which would bring 
tremendous screening efforts when combining of semi-synthetic chromosomes based on 
homology-directly recombination. Therefore, to increase the frequency of the mitotic 
recombination of the two semi-synthetic chromosomes (synII-L and synII-R), we adopted an I-
SceI mediated strategy (17) to break synII-L and synII-R at a designed site, promoting mitotic 
recombination between them to generate the fully synthetic synII (fig. S1D). Induction of the 
lethal I-SceI-mediated double-strand DNA breaks at the junctions of synthetic and wild-type 
sequence introduced a strong selective pressure for the two semi-synthetic segments to 
recombine, via a homology-directed repair mechanism. Since our recombination strategy is 
designed to generate a markerless synII and leave the URA3 marker on wild-type chromosome, 
we observed a 10-fold increase in the URA3-deficient colony numbers upon the I-SceI 
induction, as judged by marker loss screening, suggesting our strategy can greatly bias the 
crossover events towards the designated regions. The resulting synthetic chromosome II strain 
(version yeast_chr02_9.01) was identified by the PCRTag method (fig. S2, fig. S3). 
 
 
Sequencing revealed structural variations in synII 
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Compared with the designed sequence, 61 variations of 4 types were observed by deep 
sequencing: 50 single nucleotide variations (SNVs), 5 missing loxPsym sites, 4 deletions and 2 
structural variations (SVs) (table S2). 28 of the 50 SNVs were found to correspond exactly to 
the genotype of the native chromosome sequence at these positions, suggesting that these 
represent residual homologous recombination “patchworks” as seen in synIII and other 
synthetic chromosomes (12, 15, 18-21). When such patchwork regions are very short (i.e. lying 
entirely between two sets of PCRTags), they can be missed by the PCRTag analysis. For the 
remaining 22 SNVs, 3 were found to pre-exist in synthetic minichunk DNA indicating that 
these mutations were introduced during synthesis. The remaining SNVs map to overlapping 
regions between minichunks or megachunks, suggesting that these SNVs were likely 
introduced during minichunk assembly or megachunk integration. Since none of these SNVs 
are in coding regions or noticeably altered phenotype, they were not corrected.  
 
As previously seen in other larger synthetic chromosomes (synV, synX) (19, 20), we observed 
two complex structural variants (SVs):  the first of these was a ~15 kb tandem-duplication in 
megachunk L with chunk L2-L4 duplicated and a loxPsym site located between the duplications 
(fig. S5A & S5B); another SV, identified in megachunk T, was fully characterized by PGM 
sequencing (Life Technologies), and is a >30 kb complex DNA sequence including multiple 
copies of chunks T4, T5 and a partial chunk backbone plasmid pSBGAK (fig. S5A & S5C). We 
hypothesize that the 34 bp loxPsym sequence can serve as a homologous region during 
homologous recombination-mediated integration, albeit at a very low frequency, which led to 
the formation of the first SV. The mechanism of formation of the second SV remains unknown.  
 
Correction of structural variants in synII 
We designed a straightforward strategy to repair the two structural variations, again by 
applying the I-SceI system (17). The 18bp I-SceI recognition sequence was designed to carry a 
selective marker (URA3) and overlap with both ends of the tandem repeat junction as a donor 
fragment (fig. 1A). Upon induction of I-SceI digestion, the synII chromosome was broken and 
thereafter was repaired through homology-directed recombination between the repeat 
sequences, and as a consequence it effectively looped out the duplicated region.  
 
Using this strategy, we sequentially repaired the two SVs in synthetic chromosome II, yielding 
strains yeast_chr02_9.02 and yeast_chr02_9.03 respectively (fig. 1B). PCR analysis (fig. S5D) 
and deep sequencing (fig. 1C) validated the successful repair of the duplicated regions in synII. 
Duplications were also observed in other synthetic chromosomes (synV, synX, synXII). Thus 
the I-SceI mediated strategy could serve as an efficient strategy especially suitable for repair of 
large duplications in synthetic chromosome construction.  
 
In addition to the SVs, pulsed field gel analysis (PFGE) showed an abnormal chromosome 
karyotype of native chrXIII and chrXVI (fig. S6). This was further confirmed by DNA 
sequencing and Hi-C analysis (22). As similar instances also been found during the 
construction of synIII (15), we surmise that this represents a spontaneous low-frequency event 
occurred at some point during assembly. PFGE shows that the chrXIII and chrXVI karyotype of 
the synII strain with SVs (yeast_chr02_9.01) is correct. Therefore, we repaired this 
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chromosomal crossover by first switching the mating type of the repaired synII 
(yeast_chr02_9.03) and then back crossing to synII strain (yeast_chr02_9.01) to avoid 
crossover between synthetic chromosome II and native chromosome II. After tetrad dissection, 
the correct karyotype was verified by PFGE (fig. S6). 
 
Comprehensive characterization of synII (yeast_chr02_9.03) phenotype  
Growth curves, phenotype and morphology tests under various cultivation and stress conditions 
were performed to check the fitness of the repaired synII strain compared to the wild-type 
counterparts (BY4741 and BY4742) (fig. 2A & 2B). Results show that synII strains are largely 
on par with wild-type strains (fig. S7, S8, S9). We did observe a significant fitness defect 
appear after megachunk E integration. Further investigation revealed that the defect was 
introduced by the insertion of the selective marker URA3 (for integration selection) adjacent to 
the NCL1 gene, which encodes a tRNA:m5C-methyltransferase. Loss of function of NCL1 gene 
is previously reported to be involved in slow growth and temperature sensitivity (23, 24), which 
explains the  observed phenotypic defect. This auxotrophic marker interference phenotype was 
reversed in the next step of SwAP-IN, in which the URA3 marker was overwritten by an intact 
NCL1 gene. Similar instances of such reversible fitness defects were also found after 
integration of megachunk B, U, and W (fig. S8).  
 
In addition, a defect at high temperature (37°C) in medium with glycerol as the carbon source 
was observed: colony size is much smaller than wild-type. We confirmed that the slow-growth 
phenotype is recessive by crossing synII with wild type (BY4742) (fig. S10A). To ascertain the 
origin of this defect, we examined the phenotype of each intermediate strain under this 
particular condition and found that the defect appeared after the integration of megachunk X 
(fig. S10B). Using complementation assays, we identified a modification resulting from 
PCRTag recoding in YBR265W (fig. S10C). As an essential gene, YBR265W encodes 3-
ketosphinganine reductase (Tsc10p) that catalyzes the second step in the pathway for 
sphingolipid synthesis in S. cerevisiae (25). Sphingolipids are reportedly involved in the 
regulation of the yeast high-osmolarity glycerol (HOG) response pathway (26). We reasoned 
that the defect might be caused by modifications in YBR265W. On replacement with the wild-
type gene, the defect was greatly mitigated (fig. S10D). This highlights the effectiveness of the 
genome debugging mechanism provided by the modular chromosome construction strategy in 
the Sc2.0 project. Given that some defects might involve more than one bug, making the afore-
mentioned method inadequate. In this case, SCRaMbLE may be a powerful alternative 
approach for targeting the defect. We have demonstrated the feasibility of this approach by 
quickly evolving synII strain to identify and overcome a design problem. By turning on the 
SCRaMbLE system in synII cells and directly plating the SCRaMbLEd population on the 
defect-causing condition, we identified a few large colonies that resemble wild type (fig. S11A). 
From two large colonies we isolated for sequencing, no rearrangement was observed within the 
YBR265W region. However, all genomic rearrangements on synII involve genes coding for 
regulatory proteins that have either genetic or physical interactions with HOG regulatory 
proteins (fig. S11B). Interestingly, we observed that a phenotypic defect can be recovered 
through a number of alternative routes in the complex cellular interactome network. 
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As more and more individual synthetic chromosomes are finishing and will be merged into a 
single haploid cell, we successfully merged synII and synIII using method established 
previously (18). The resulting synII/III cell grows just like native cells (fig. S12), indicating 
that synII can be successfully incorporated into another synthetic background without 
introducing growth defects. 
 
Segregation and replication of synII  
Once synII was constructed and phenotypically profiled, a logical next question is to ask how 
this synthetic chromosome replicates and segregates. Therefore, to further investigate whether 
the modifications to synII might introduce subtler chromosome damage not detected in large-
scale phenotypic assays, we examined and compared DNA replication and segregation 
processes during the cell cycle in synII and WT (BY4741) strains by tagging synII with an array 
of tet operators and using the previously described TetR-GFP method (27).  Here, synII and 
WT cells were released from a G1 block synchronously into the cell cycle (fig. S13). The 
progression of cells from metaphase to anaphase was identified by spindle morphology. We 
scored separation of sister chromatids at CEN2, by counting the percentage of cells in which 
two GFP dots were visible in both synII and BY4741 strains and found them to be comparable 
(fig. 2C). Calculation of the overall ratio of metaphase to anaphase spindles and flow cytometry 
analysis (FACS) of DNA content provided further evidence for normal cell cycle progression 
in the synII strain (fig. 2C, fig. S14).  
 
Early activating replication origins are frequently adjacent to tRNAs and transposable 
elements containing Long Terminal Repeats (LTRs) (28). In synII, two early origins are no 
longer linked with tRNAs and LTRs, as they were removed by design. Therefore, synII offers 
an opportunity to test whether this correlation represents a functional relationship. We 
determined the replication dynamics for synII and demonstrated that the synthetic chromosome 
showed identical replication dynamics to the wild-type chromosome II (fig. 2D). This finding is 
consistent with the linkage between early activating origins, tRNAs and LTRs not being a 
functional requirement for early origin activation.  
 
Our results show that synII exerts no gross negative effect on key cell cycle transitions; 
including chromosome replication (S phase) and segregation of sister chromatids (anaphase). In 
additional, Hi-C analysis of synII also revealed no substantial changes between synthetic and 
native chromatin, suggesting that the designed sequence has little of no effect on the average 
global folding of the chromosome (22). 
 
synII Trans-Omics analysis reveals genome plasticity 
We used a systems biology approach (“Trans-Omics” analysis) to probe the impact of synII on 
the genomics, transcriptomics, proteomics and metabolomics of S. cerevisiae. The insertion of 
267 loxPsym sites in synII could affect genomic stability; therefore we evaluated genome 
integrity and the loss frequency of chromosome segments in the absence of Cre expression. 
PCRTag analysis showed that no deletions were observed in 27 independent isolates derived 
from over 130 mitotic generations from 9 independent lineages (fig. S15A & S15B). The 
overall loss rate was estimated at lower than 5.9 x 10-6. In addition, the deep sequencing 
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analysis of 9 derived single strains showed that no mutation or genome rearrangement was 
observed, indicating that genome stability was maintained faithfully even after 100 generations 
of nonselective growth (fig. S15C). Transcriptome profiling identified only 18 out of 6,561 
genes to have differential mRNA expression in comparison to the wild-type, with 7 up-
regulated and 11 down-regulated (FDR < 0.01 and p-value < 7.62E-06, fig. 3A, table S3). In 
the proteomics analysis, mass spectrometry was performed on synII and BY4741 strains. Mass 
spectrometry provided abundance data for 3,965 out of 6,682 protein-coding genes, and only 6 
proteins showed substantial differential abundance in synII compared with wild-type (fig. 3B, 
table S4).  Finally, metabolic LC-MS analysis was performed for metabolomics profiling. In 
total 4,941 and 6,417 mass spectra peaks with CV <30% were identified in positive and 
negative mode respectively, mapping to 1,032 unique metabolites, Fewer than 0.78% of the 
metabolites were differentially represented (fig. 3C & 3D). Potential differentially regulated 
metabolites included sphingolipids, glycerophospholipids, steroids and steroid derivatives 
(table S5, table S6). Interestingly these are all molecules associated with membranes. 
 
Moreover, we also observed cellular perturbations that potentially arise from the Sc2.0 overall 
design principles. Compared to the WT strain, a subtle but potentially biologically significant 
up-regulation of genes with the GO terms “ribosome” and “cytoplasmic translation” was 
observed in the synII strain on both the transcriptome and proteome level (fig. 3E, fig. S16A, B, 
C, D & E). Similar up-regulation was also observed in the synV and synX transcriptome (fig. 
S17). As previously reported, deletion of multi-copy tRNA genes can lead to increased 
expression of translation machinery (29), thus we reasoned that the up-regulation of 
translational function might be caused by the 13 tRNA genes deleted in synII, which are all 
from multi-copy tRNA gene families. RNAseq analysis of synII with the tRNA array 
(yeast_chr02_3_9.03, strain YCy1193) verified our hypothesis: the introduction of tRNA array 
to synII greatly diminished upregulation of translational functions (fig. 3F).  
 
In summary, despite these very specific and subtle differences, the Trans-Omics analysis 
provides explicit evidence that biological processes within the synII strain are highly consistent 
with the wild-type strain. Therefore, the yeast genome displays a great degree of plasticity, and 
can readily cope with the large degree of editing encoded into synII.  
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Conclusions 
 
In previous reports, the entire Mycoplasma genitalium genome was synthesized from 
oligonucleotides, assembled in budding yeast into a complete genome (9, 30). The genome 
transplantation method heavily depends on accurate design of a viable genome, and the low 
success rate of the transplantation step (and a lack of knowledge about how generically it can 
be done) makes it challenging to restore fitness when defects arise. In contrast, the Sc2.0 
consortium uses a modular construction approach to progressively swap the wild-type 
chromosome with its designer counterpart as illustrated for the first time (15), and many 
finished chromosomes (18-21). The modular approach provides an important mechanism to 
systematically dissect and repair phenotypic defects, exemplified by the elimination of a 
growth defect on a specific carbon source that we here found to be caused by a 25 bp PCRTag 
sequence in a 770 kb chromosome. Similar debugging success has been reported in other 
synthetic chromosomes (18, 19, 21). Another advantage of modular assembly is that it enables 
multiple teams to collaborate and construct synthetic chromosome in parallel. The modular 
approach also permits parallel construction of individual chromosomes. In this study, we have 
constructed synthetic chromosome II from both ends. Other innovative approaches with the 
shared goal of parallelized construction are possible; synXII was constructed in 6 parallel 
production strains (a method termed Meiotic Recombination-mediated Assembly), which can 
further promote the construction efficiency (21). Future efforts can be planned through the 
attempt to join the complementary advantage of our approach to this method to develop more 
efficient construction method. 
 
Our comprehensive phenotypic assays of synII strains revealed the extensive plasticity of the 
yeast genome. An important Sc2.0 design goal was to be conservative by avoiding changes 
likely to affect fitness-related phenotypes. Results with synII and other single synthetic 
chromosome strains suggest that the design has been successful in avoiding major fitness 
defects. However, interesting subtle patterns of differential gene expression were revealed by 
looking for enriched GO terms in the transcriptome and proteome analyses. It may be 
premature to suggest that the Sc2.0 design is too conservative, since strains hosting multiple 
synthetic chromosomes may have more profound phenotypic differences from the wild type 
due to the interactions among designer features in different chromosomes. A Trans-Omics 
approach will be a powerful way to capture subtle changes in the interactome network at 
various levels. Our design objective for the Sc2.0 genome is not to create a strain that encodes a 
particular phenotype; rather our goal is to create a robust, high fitness, engineerable chassis for 
unbiased exploration of the viable genotype to phenotype space using SCRaMbLE induction 
under various conditions. This goal is in contrast to more standard synthetic biology goals to 
engineer a single, specific phenotype or metabolic capability. Prior pilot studies provide strong 
evidence that SCRaMbLE works as designed as an effective approach to generate an unbiased 
exploration of the enormous design space for synthetic chromosomes (11, 31).  
 
In conclusion, we have demonstrated that synII segregates, replicates and functions (at the 
Trans-Omics level) in a very similar way to its wild-type counterpart which has naturally 
evolved over millions of years. We conclude that synII fits the design objective and is ready to 
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be integrated into the final Sc2.0 genome with the joint effort of the entire Sc2.0 community in 
the near future.   
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Materials and Methods 
SynII Design 
We designed synII based on the version of S288C-derived strains available as of [30/11/2011] on SGD 
(http://downloads.yeastgenome.org/sequence/S288C_reference/genome_releases/, Version ID: 
S288C_reference_genome_R64-1-1_20110203). Genome editing suite BioStudio (14) was used to conduct 
the in silico design of synII, with the final version being yeast_chr02_3.25. Compared to native chromosome 
II, the resulting 770,035 bp synII sequence is altered on average once in every 467 bp, and has a total of 
~10.26% sequence alteration. 22 of 30 introns from protein-coding genes were removed from synII, with the 
remaining 8 retained because they are either known to lead to a fitness defect when deleted or they are 
ribosomal proteins genes and deletion of such introns may lead to fitness defects (32). More design details 
can be found in Table S1 and on the synthetic yeast project website (http://www.syntheticyeast.org). 
 
synII Segmentation  
Once synII design was completed, segmentation of synII into megachunks (~30 kb) and chunks (~10 kb) was 
performed using BioStudio (14). By applying an in-house developed program called SegMan, each chunk 
was segmented into minichunks (~3 kb). Minichunks were designed to be assembled into chunks by Gibson 
assembly (16) (see “Minichunk Assembly” section), and therefore 40 bp overlaps between each adjacent 
minichunks were added by SegMan. Terminal restriction endonuclease sites were also added on both ends of 
each minichunk to allow excision from the plasmid with the requirement that only 5 sticky or blunt ends 
could be generated by digestion. The 40 bp overlap regions were chosen based on following criteria: minimal 
free energy > –3 kcal/mol, and melting temperature (Tm) of 68±4 °C. Higher free energy of overlap 
sequence leads to reduced probability of self-folding of single-stranded DNA and results in higher efficiency 
for overlap-based in vitro assembly methods (33), such as Gibson assembly (16) and USER assembly (34). 
Here the RNAfold program of the ViennaRNA Package 2.0 (35) was used to calculate the minimal free 
energy of the DNA sequence. A simplified formula (36) was applied to estimate the melting temperature: Tm 
= 945*ΔH/(ΔS + R*log(0.0001)) – 273.15, in which ΔH is enthalpy (kJ/mol), ΔS is entropy, R is the molar 
gas constant (1.9872 cal/mol-K). In addition, to reduce synthesis cost, LEU2 and URA3 markers were 
designed separately as independent cassettes and used repeatedly in minichunk assembly.   
 
 
synII Synthesis and Assembly 
 
Minichunk Assembly 
Synthesis of ~3 kb minichunks was outsourced to Invitrogen, Genscript and BGI Tech. pSBGAA or pSBGAK 
(sequence information can be found at www.syntheticyeast.org) was chosen as the accepting vector of chunks. 
Minichunks were excised from the plasmids using the terminal restriction sites. BamHI was used to linearize 
the chunk-accepting vectors pSBGAA (AmpR) and pSBGAK (KanR). The chunks were assembled using 
Gibson assembly strategy (16) with a modified recipe: 1 μL of Taq ligase (New England Biolabs) was added 
in the final volume of 20 µL for each reaction. The molar ratio of accepting vector to minichunk DNA was 
1:5. After thorough mixing, a one-hour incubation at 50°C was performed. Then 10 µL of the reaction 
mixture was transformed to 50 µl E.coli DH5α competent cells (TAKARA). For assembly verification, single 
colonies were selected for overnight culture at 37°C. After miniprep, restriction digestion of the terminal 
restriction sites was performed to verify the assembly result. 
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Chunk and Junction Preparation  
Once verified by restriction digestion, the component chunks of each megachunk were digested using the 
terminal restriction sites and gel purified. For each megachunk, 1 µL of each chunk DNA, 0.5 μL of T4 DNA 
ligase (New England Biolabs) and ddH2O were added to a final volume of 10 µL and mixed well for an 
overnight ligation at 16°C. Then the reaction product was diluted 1:10 and used as template to amplify ~1 kb 
junction fragments with the corresponding primers (primer sequence information can be found at 
www.syntheticyeast.org) using Phusion DNA polymerase (New England Biolabs). After gel verification, 
junction fragments were purified using a PCR cleanup kit (Axygen).  
 
Replacement of WT Yeast Chromosome II with Synthetic Chunks 
BY4741 (MATa his3Δ1 leu2Δ0 LYS2 met15Δ0 ura3Δ0) containing the KanMX marker (strain ID: YS000-L) 
and BY4742 (MATα) containing the URA3 marker (strain ID: YS000-R) were used as the initial strains for 
synthetic megachunk replacement from the left arm and right arm, respectively. The URA3 and LEU2 
selectable markers were used iteratively for replacing the native sequences of chromosome II with synthetic 
chunks. Together with the ~1 kb junction fragments (consisting of ~500 bp overlaps with two adjacent 
chunks), the chunks constituting each megachunk were co-transformed using the LiOAc transformation 
protocol (15) with 300 ng of each chunk DNA and 200 ng of each junction DNA added. The transformation 
products were re-suspended in 100 μL 5 mM CaCl2 and plated on an appropriate selectable media (SC–Ura 
or SC–Leu) with serial dilutions where appropriate. After 18 successive rounds (left arm initiated) and 8 
successive rounds (right arm initiated) of replacements, two semi-synthetic chromosomes were successfully 
constructed, with one containing synthetic megachunks A-R (synIIA-R, strain ID: YS018) and the other 
containing synthetic megachunks R-Y (synIIR-Y, strain ID: YS026). The selectable marker URA3 in synIIR-Y 
was removed through yeast transformation with the corresponding markerless synthetic fragment and 
screened with 5-FOA (37).  
 
Integration of parallel constructed semi-synthetic chromosomes 
An I-SceI (38)-mediated method was developed to combine the two semi-synthetic chromosomes, synIIA-R 
and synIIR-Y. For synIIA-R, a fragment (I-SceI-URA3) containing the I-SceI recognition sequence and URA3 
was designed to have a 40 bp overlap upstream and downstream of the LEU2 marker on synIIA-R. A 
previously described method (39) was used to integrate the I-SceI-URA3 cassette into synIIA-R to replace 
LEU2 marker (strain ID: YS027). Following the same strategy, the I-SceI-URA3 cassette was inserted into 
synIIR-Y with the URA3 marker residing in wild-type sequence at the upstream end of megachunk R. In 
addition, a LEU2 marker was inserted into synIIR-Y at the upstream of the centromeric region of synIIR-Y 
within gene YBL005W (strain ID: YS028). Mating of the synIIA-R strain (MATa, strain ID: YS027) and 
synIIR-Y (MATα, strain ID: YS028) was performed by overnight co-culturing in 3mL YPD medium at 30°C. 
The I-SceI expression vector pRS413-pGAL-I-SceI was transformed into the diploid cells followed by plating 
on SC–His plate. Single colonies were selected for overnight culture in 3 mL SC–His/glucose medium. The 
overnight culture was then added to 20 mL SC–His/raffinose (2% raffinose and 0.1% glucose) to reach an 
initial OD600 of 0.1 and incubated until OD600 reached 0.4 (~4-hour). Cells were harvested by centrifugation 
at 6,200 rcf for 5 min and re-suspended in 20 mL SC–His/galactose (2% galactose). After a 2-hour I-SceI 
induction on galactose media, 20 µL cells were inoculated into 3 mL YPD medium, followed by overnight 
culture at 30°C. Overnight culture (1 mL) was harvested by centrifugation at 13,800 rcf for 1 min. The 
pellets were re-suspended in 200 µL ddH2O, patched on a SPOR plate and incubated at room temperature for 
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1 day. Then 5-7 days incubation at 30°C was performed until a significant number of tetrads was observed. 
 
Cells were re-suspended in 25 μL Zymolyase-20T (25 mg/mL in 1 M sorbitol), then incubated at 37°C, with 
shaking at 800 rpm for 60 min. Then 500 µL ddH2O was added and mixed thoroughly, followed by plating 
on 5-FOA plates and incubating at 30°C for 3 days. Then replica plating on SC–Leu and YPD plates was 
performed, followed by 24 hours incubation at 30°C. FOAR Leu– colonies were selected from YPD plates, 
inoculated into 3 mL YPD medium, and cultured overnight. To verify the integration of semi-synthetic 
chromosomes, one pair of synthetic PCRTag and wild-type PCR tag were chosen from each megachunk (in 
total 25 pairs) to perform PCRTag analysis. Then sequencing was performed for further verification. 
 
Yeast Genomic DNA Preparation for PCRTag analysis 
Yeast cells were collected from 0.5 mL of overnight culture by centrifugation at 13,800 rcf for 1 min. Pellets 
were resuspended in 100 μL breaking buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.1 M NaCl, 2% Triton 
x-100, 1% SDS). Glass beads (0.1 g, 0.5 mm of diameter) and 200 μL PCI (Phenol: Chloroform: Isoamyl 
alcohol= 25:24:1) were added and the mixture was vortexed at maximum speed for 3 min. Then 100 μL 
ddH2O was added and the mixture was centrifuged at 13,800 rcf for 5 min. Supernatant (150 μL) was 
transferred to a microcentrifuge tube.  
 
PCRTags Analysis Reaction setting 
PCRTag amplification was performed using rTaq Polymerase (TAKARA). Forward and reverse PCRTag 
primer pairs (400 nM each, detailed information of PCRTag primers can be found at www.syntheticyeast.org), 
1 μL BY4741/synII genomic DNA and 2.25 µL ddH2O were added to a final reaction volume of 12.5 µL. The 
PCR thermal-cycler program setting was as follows: 94°C/5 min, 30 cycles of (94°C/30 sec, 55°C/30 sec, 
72°C/30 sec), and a final extension of 72°C/5 min. Detection of PCRTags was carried out by gel 
electrophoresis. PCR product (3 µL) was loaded onto a 2% agarose gel, and electrophoresis was performed at 
180V for 20 min. 
 
Yeast Genomic DNA Preparation for DNA Sequencing 
Yeast cells were grown in 5 mL YPD medium using a 14 mL round bottom tube for 2 days till saturation. 
Pellets were collected by centrifugation at 13,800 rcf for 1 min. Breaking buffer (400 μL) was added to re-
suspend the pellet. Glass beads (0.2 g, 0.5 mm of diameter) and 400 μL PCI (Phenol:Chloroform:Isoamyl 
alcohol=25:24:1) were added, the re-suspension was vortexed at maximum speed for 3 min, and then 
centrifuged at 13,800 rcf for 10 min. 400 µL of the aqueous layer was transferred to a new 1.5 mL tube. The 
genomic DNA was precipitated by adding 400 μL of isopropyl alcohol and kept at room temperature for 5 
min. Then genomic DNA was pelleted by centrifugation at 13,800 rcf for 10 min. The pellet was washed with 
500 μL 70% ethanol, followed by 5 min drying at 37°C. The genomic DNA was re-suspended in 50 μL TE 
buffer (10 mM Tris-HCl pH8.0, 1mM EDTA) with RNase (25 μg/mL) and incubated at 37°C for 30 min.  
 
Nucleotide Sequence Analysis of synII with Hiseq2500 sequencing platform 
Library preparation and whole genome sequencing 
Paired-end whole genome sequencing was performed for the synII (yeast_chr02_9.01, strain ID: YS029) on 
the HiSeq2500 platform. A 500-bp library was prepared according to standard Illumina DNA preparation 
protocols. 
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Sequencing quality control and mapping to genome sequence 
Before mapping of reads, quality control of sequencing reads was performed. Reads with adapters or shorter 
than 90 bp were removed. Reads with more than one base having a Phred-score below 10 or with more than 
one unknown base were removed, leaving 673 Mbp cleaned paired-end reads, with 55.6-fold sequencing 
depth of the genome. Cleaned reads of each sample were mapped to yeast reference sequences (the original 
sequence of chromosome II being replaced by synthetic chromosome II sequence) using BWA 0.5.6 (40) 
with standard settings. For each alignment result, local realignment was performed with GATK 2.7-2 
RealignerTargetCreator and IndelRealigner tools (41) to clean up mapping artifacts caused during reads 
mapping on the edges of indels. The resulting files in BAM format were then prepared for initial SNV/indel 
calling. 
 
Identification of SNVs and indels 
Both Samtools (42) and GATK 2.7 (41) pipelines were used to identify the SNVs and indels using default 
parameters. The variants were filtered by the criteria of QUAL < 50 or PV4 < 0.1,0.1,0.1,0.1 or MQ <10 or 
DP < 10 or DP4 < 0,0,3,3 for Samtools results and QUAL < 50 or FS >3 or BaseQRankSum >3 or 
MQRankSum>3 or ReadPosRankSum>3 or MQ <10 or DP < 10 for GATK results. The variants identified by 
either tool were merged with CombineVariants implemented in GATK. The merged variants in the synthetic 
chromosome were checked manually using Tablet (43) to exclude false-positive results caused by sequencing 
or mapping errors. Annotation was performed for observed variants, with the following types: synonymous 
type, non-synonymous type, frameshifts, and variant outside coding region (Table S2). 
 
Identification of loxPsym sites 
In synIII, loxPsym sites can be absent from expected locations (15). To check whether all loxPsym sites are 
present in synII, sequencing reads containing loxPsym sites were extracted from the whole read library for 
identifying the presence of all expected loxPsym sites. For each loxPsym site, the read mapped span the 
loxPsym site of upstream and downstream flanking sequence >10 nucleotides and the sequenced loxPsym 
site with bases of >=24 matching or mismatching loxPsym sequence was recognized as a loxPsym read and 
bases of >=15 deleted was counted as a “loxPsym_lost” read (Table S2). The loxPsym site with p-value of < 
0.001, which estimated by Poisson mode, and supporting read number >=5 was identified as a loss of 
loxPsym site.  
 
Structural variant detection with the PGM sequencing platform 
Library preparation and whole genome sequencing 
A 400-bp DNA library of a synII (yeast_chr02_9.01, strain ID: YS029) was prepared for single-end whole 
genome sequencing according to the Life Tech standard preparation protocol using the Ion Xpress™ Barcode 
Adapter 1-96 Kit (Cat.no.4474517) and sequenced on the Ion PGM™ platform. Quality control of 
sequencing reads was performed. Reads shorter than 30bp or duplicated were removed. Reads with more 
than 1% of bases having a Phred-based quality score <10 or with unknown bases were trimmed first to meet 
the filtering criteria and removed if the first trimming step failed, leaving 488 Mbp cleaned reads, with 32.6-
fold sequencing depth of the genome and 248 bp average length. Cleaned reads of each sample were mapped 
to synthetic yeast genome sequences using bowtie2-2.0.0 (44) with standard settings. 
 
Structural variant reconstruction 
To identify whether structural variations exist in synII, reads that did not map to the reference genome were 
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split to pairwise ends (split reads, at least 30 bp) by scanning over all intermediate positions at least 30bp 
from the ends of the read. Then these pairwise ends were then aligned to the reference using Bowtie2 (44) by 
single-end mapping with parameter –k 100. The pairwise ends that matched parental sequence were analyzed 
for breakpoints to provide direct evidence for structural variants. One read was assigned as the most probable 
mapping type based on five priorities: no recombination events (top priority), intra-chromosome 
recombination, inter-chromosome recombination within wild-type chromosomes and external chromosome 
recombination between synthetic and wild-type chromosomes, and single end mapping. For each identified 
breakpoint, a 5 bp error range was allowed. These reads at a breakpoint site with at least 3 supporting reads 
were locally assembled using PolyPhred (45), and then the assembly results were annotated by Blastn against 
the reference containing the selection marker and acceptor vector and wild-type chromosome II sequence to 
identify the potential extrinsic sequence. Combining the split-read mapping, sequencing depth and local 
assembly contigs, the structural variations were reconstructed (Fig. S5). 
 
synII Structural Variant Correction 
An I-SceI mediated transformation strategy was designed to correct the two structural variations observed in 
Megachunks L and T of synII (yeast_chr02_9.01, strain ID: YS029). For the duplication in Megachunk L, a 
donor fragment containing the URA3 sequence and an I-SceI site (TAGGGATAACAGGGTAAT) was 
designed to carry 40 bp overlapping regions at the end of the original chunk L4 and the beginning of 
duplicated chunk L2 (Fig. 1B). The donor fragment was produced by PCR using primers including the I-SceI 
site and overlap sequence. I-SceI expression vector pRS413-pGAL-I-SceI and the donor fragment were co-
transformed into the synII strain (strain ID: YS029). After I-SceI induction on galactose media, cells were 
plated directly on 5-FOA plates directly and incubated at 30°C for 3 days. Then FOAR colonies were selected 
and cultured overnight in YPD medium at 30°C. Confirmation of repair was performed by PCR using a pair 
of primers designed to amplify across the L4-L2 breakpoint (primer sequence information can be found at 
www.syntheticyeast.org).  
 
For the complex variation in Megachunk T, a donor sequence was designed to contain a URA3 cassette and 
the I-SceI site, with the left end overlapping with the right end of chunk T4 by 500 bp, and the right end 
overlapping with the left end of chunk T5 by 500 bp (Fig. 1B). Both 500 bp overlapping sequences and the I-
SceI-URA3 cassette were produced by PCR with 40 bp overlaps with each other and assembled together 
through the Gibson assembly method (16) to form the donor fragment. An additional 100 bp of chunk T4 was 
added between the I-SceI-URA3 cassette and 500 bp overlapping sequence of T5 to facilitate the homologous 
recombination. The donor fragment and I-SceI expression vector pRS413-pGal-I-SceI were then co-
transformed into the synII (yeast_chr02_9.02, strain ID: YS030) in which the structural variation in 
Megachunk L had been repaired. I-SceI induction was performed on galactose-containing media and colonies 
were screened on 5-FOA-containing plates. PCR verification was then performed with 8 pairs of verification 
primers designed across each breakpoint observed in this structural variation (Fig. S5D). The synII 
(yeast_chr02_9.03, strain ID: YS031) was sequence-verified again using the PGM sequencing platform, with 
library preparation and sequencing method as described in “structural variant detection with the PGM 
sequencing platform”. 
 
Mating Type Switch of Yeast 
pJD138 (pGAL-HO) was transferred into the SynII strain (yeast_chr02_9.03, strain ID: YS031) using the 
LiOAc transformation protocol (15), followed by overnight culture in 5ml SC–Ura/galactose (2% galactose) 
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liquid at 30°C. The mating type was then determined by crossing with MATa and MATα tester strains and 
confirmed by microscopy. 
 
Mating and Sporulation 
A synII (yeast_chr02_9.01, strain ID: YS029) and a second synII (yeast_chr02_9.03) strain that had its 
mating type switched to alpha (strain ID: YS032) were recovered on YPD plates. synII (yeast_chr02_9.01) 
colonies and synII (yeast_chr02_9.03) colonies were picked and patched in the same section (mating section) 
on a new YPD plate with an inoculating loop, followed by overnight culture at 30oC. Then diploid colonies 
were patched on SPOR plates [10 g potassium acetate (Sigma), 1.25 g yeast extract (Oxoid), 1 g glucose 
(Sangon Biotech), 20 g agar (Sangon Biotech), ddH2O up to 1 L] and left at room temperature for one day, 
followed by 8 days incubation at 30°C. Then cells were taken from SPOR plates and re-suspended in 25 μL 
zymolyase solution (MP Biomedicals, 1 mg/ml Zymolyase in 1M sorbitol), followed by 25 min incubation at 
37°C. Cells were checked under the microscope to determine zymolyase efficiency. After tetrads were 
appropriately digested, 500 μL ddH2O was added and the suspension mixed vigorously by vortexing to break 
up the tetrads. Then a series of 10-fold dilutions were made before plating on YPD plates. The plates were 
incubated at 30°C for 2-3 days. Single colonies were picked and streaked on fresh plates, followed by 
overnight incubation. Mating type of random spores was confirmed by crossing with MATa and MATα tester 
strains and confirmed by microscopy. Spore-derived colonies were selected for PCR verification. The nine 
pairs of primers used for identifying breakpoints in SynII (yeast_chr02_9.01) were used here to verify the 
correct synII sequence (primer sequence information can be found at www.syntheticyeast.org). Pulsed-field 
gel electrophoresis (PFGE) was performed for karyotype analysis. Finally, candidates were further verified 
using the PGM sequencing platform, with library preparation and sequencing method as described in 
“structural variant detection with the PGM sequencing platform” above. 
 
Pulsed-field Gel Electrophoresis 
Samples were prepared for pulsed-field gel electrophoresis (46). Identification of chromosomes was inferred 
from the karyotype of WT (BY4741, BY4742) on the same gel. Samples were analyzed on a 1.0% agarose gel 
in 1×TAE (pH 8.0) for 22 hrs at 14°C on a CHEF apparatus. The voltage was set to 5 V/cm, at an angle of 
120°. Switch time was set to 60 – 90 sec ramped over 22 hrs. 
 
Genome Stability Analysis 
The synII (yeast_chr02_9.03, strain ID: YS031) was streaked on YPD plate for 2 days and incubated at 30°C. 
Nine single colonies were selected for successive subculture in YPD medium for ~130 generations, followed 
by plating on YPD plates overnight. Three single colonies of each initial isolate were selected. Genomic 
DNA preparation was performed for all 27 isolated single colonies. 48 pairs of PCRTags were chosen to 
perform PCRTag assay for all 27 isolated single colonies. Sequencing on the PGM platform was conducted 
for 9 of the 27 isolated single colonies (one from each initial isolate), with library preparation and sequencing 
method as described in “structural variant detection with PGM sequencing platform” above. Sequence data 
were analyzed according to the method described in “Nucleotide Sequence Analysis of synII with Hiseq2500 
sequencing platform” above. 
 
Cre SCRaMbLE of synII 
BY4741 and synII (yeast_chr02_9.03, strain ID: YS033) with pSCW11-CreEBD-His3 plasmid (47) were 
cultured in SC–His liquid media overnight at 30°C, with duplicates for each strain. Cells were inoculated into 
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SC–His liquid medium with 1 μM EST and cultured for 24 hrs at 30°C. Then cells were washed, serial 
dilution and spotting were performed on YPG plates, followed by 4 days incubation at 37°C. 
 
Yeast Total RNA Isolation for RNA Sequencing 
The synII (yeast_chr02_9.03, strain ID: YS031) and BY4741 strain both with 3 biological replicates were 
cultured overnight in 3 mL YPD medium at 30°C. The cultures were added to 10 mL fresh YPD medium and 
incubated until the OD600 reached ~0.8. The cells were harvested by centrifugation at 900 rcf for 5 min. Total 
RNA was isolated using the RiboPure-yeast kit (Ambion) according to the manufacturer’s instructions.  
 
RNA-seq Analysis of synII 
The 330 bp cDNA libraries were prepared according to the manufacturer’s instructions (Illumina Inc.) and 
were paired-end sequenced using the Illumina Hiseq2500. Raw read data were filtered using the following 
criteria: no N bases, no adaptor sequences, minimum read length 100, bases of low quality (<10) was no 
more than 1% in a read. An average of 7.0 M and 8.6 M clean reads were obtained from BY4741 and synII 
(yeast_chr02_9.03, strain ID: YS031) samples respectively, with 95.7% and 95.2% mapped to the 
corresponding genome reference. Cleaned reads were mapped to genomes by tophat v2.0.10 (48), with the 
parameter –r (--mate-inner-dist) of 130. After reads counting, RPKM was calculated for each gene. 
Differential gene expression was analyzed by DEseq v1.20.0 (49), with the no replicates scenario 
(parameters were: --method blind, --sharingMode fit-only, --fittype, local). For each gene, we obtained a raw 
p-value and adjusted p-value using the Benjamini–Hochberg procedure. Genes were assessed for statistical 
significance by rejecting the null hypothesis if the adjusted p-value (FDR) was <0.01 and if the raw p-value 
fell below the threshold of the 5% Family Wise Error Rate (FWER) after Bonferroni correction 
(threshold=7.62E-06). False positive results were inferred by the following rules and removed: dubious genes, 
transposable genes, genes with low coverage (<60%) for native and synthetic strains. 
 
Proteome and Metabolone Analysis of synII 
BY4741 and synII (yeast_chr02_9.03, strain ID: YS031) strains with 3 biological replicates were cultured 
overnight in 3 mL YPD medium at 30°C and re-inoculated in 10 mL fresh YPD medium for further 
incubation until the OD600 reached ~0.8. The cells were collected for both proteome and metabolome analysis. 
Proteins from the yeast cell were extracted with Urea, reduced, alkylated, digested with trypsin and iTRAQ 
labeled- BY4741 (113, 115, 117, 121) and synII (114, 116, 118 and 119) (AB SCIEX, Framingham, MA, 
USA). After labeling, the peptides were fractionation with SCX method and analysis by an Orbitrap Q 
Exactive mass spectrometer (Thermo Fisher Scientific, San Jose, CA) coupled with an online HPLC. Mascot 
and IQuant (50) software were used for protein identification and quantification.  
For the global metabolomics, metabolites were extracted with buffer (50% methanol and 50% water), 
separated with a BEH C18 column. For the lipidomics, metabolites were extracted with buffer (75% 
dichloromethane and 25% methanol), separated with a CSH C18 column. The metabolites were detected by a 
XEVO-G2XS QTOF mass spectrometer (Waters, Manchester, UK) and the raw spectrums were processed by 
Progenesis QI 2.0 software (Nonlinear Dynamics, Newcastle, UK) for peak picking, alignment, 
normalization and identification. Further statistical analysis was performed on the resulting normalized peak 
intensities using in-house developed software metaX. Pathway analysis was conducted using the 
MetaboAnalyst pathway tool (51). 
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Yeast KEGG pathway and GO enrichment 
To identify differentially active biological processes between synII (yeast_chr02_9.03, strain ID: YS031) and 
BY4741 strains, gene enrichment and co-expression enrichment analyses were performed using yeast KEGG 
pathways and yeast Gene Ontology (GO) annotations integrating transcriptomics, proteomics and 
metabolomics data respectively. Genes and metabolites with differential expression of log2 (fold-change) >0 
and down-regulation of log2 (fold-change) < 0 were considered as up-regulated and down-regulated for 
enrichment analysis. The significance of each KEGG pathway and GO term in genes, metabolites and co-
expression was individually identified using the hyper-geometric test and Chi-squared test with false 
discovery rate (FDR) correction(52) and the threshold P-value < 0.001. The KEGG category and interaction 
with genes of metabolites were classified based on the Yeast Metabolome Database (53) 
(http://www.ymdb.ca/system/downloads/current/ymdb.json.zip). 
 
Growth Curve Assay 
The growth curve analysis of BY4741, BY4742, and synII (yeast_chr02_9.03, strain ID: YS031) was carried 
out using a Bioscreen C system (Oy Growth Curves Ab Ltd). Overnight cultures with 3 replicates were sub-
cultured into 300 μL of the different media to final OD600 of ~0.1 in the 96 well micro-plates. Medium was 
also added as blank.  
 
Serial dilution assay on various types of media  
BY4741, BY4742, all intermediate strains (strain ID: YS001-YS026), and synII (yeast_chr02_9.03, strain ID: 
YS031) were inoculated in YPD medium at 30°C overnight. Then 1:10 serial dilutions were performed using 
these samples onto different medium plates, which including: YPD, YPD with MMS (testing for defective 
DNA repair), YPD with benomyl (microtubule inhibitor), YPD with Camptothecin (topoisomerase inhibitor), 
YPD with Hydroxyurea (testing for defective DNA replication), YPD with various final concentrations of 
Sorbitol (osmotic stress 0.5 M, 1 M, 1.5 M, 2 M, to cause osmotic stress), synthetic complete (SC) medium, 
SC with 6-Azauracil (testing for defective transcription elongation), YPEG (respiratory defects) containing 2% 
Glycercol and 2% Ethanol (testing for respiratory defects), and YPD adjusted to pH 4.0 and pH 9.0 with HCl 
and NaOH (testing for vacuole formation defects. Two specific drugs, Hydrogen peroxide (testing for 
oxidative stress) and Cycloheximide (testing for defective protein synthesis), were added to overnight 
cultures to treat the cells for two hours. Yeast cells were collected by centrifugation and resuspended in water 
before serial dilution and plating. For different medium types, plates were incubated at 25°C /30°C /37°C for 
2/3/4 days (Fig. S8). 
 
Cell Morphology 
Cells were grown to log phase in YPD at 30°C. DIC Images were collected using a Nikon microscope Ti-E 
(100X) with an Andor Zyla 5.5 camera (Fig. S9). 
 
CEN2-GFP Strain Construction and Culturing 
To create the CEN2-GFP strain, a 950 bp region to the right of CEN2 was cloned into AMp327 (27) and 
integrated into the synII strain (yeast_chr02_9.03，strain ID: YS031) and BY4741 carrying tetR-GFP, 
generating a GFP label 15 kb to the right of CEN2 (Strain ID: YCy922, YCy1018). Cell cycle synchronization 
of CEN2-GFP strains was performed by adding alpha factor in YEP medium. Alpha factor was removed by 
filtration and washing with YEP medium. Three hour mitotic time courses were performed at room 
temperature unless otherwise stated. 
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Microscopy 
Methods of fixing cells for GFP-labeled chromosome visualization and indirect immunofluorescence 
described previously were used in this study (27). Tubulin was visualized using an anti-rat antibody at a 
dilution of 1:50 in PBS/BSA and an anti-rat FITC antibody at a dilution of 1:16.67 in PBS/BSA. Microscopy 
was performed on a Zeiss Axioplan 2 microscope and images were captured using a Hamamatsu camera 
operated through Axiovision software. To score GFP dots and spindles in mitosis, cells (Strain ID: YCy922, 
YCy1018) were co-stained with DAPI to visualize nuclear morphology (Fig. S13). For each sample obtained 
at each 15 min time point, 200 cells were counted in the field to score GFP dots and spindles. 
 
FACS Analysis 
Methods of flow cytometry described previously were used in this study (27). Cells were fixed in 70% 
ethanol at 4°C overnight. Cells (Strain ID: YCy922, YCy1018) were then treated with RNase (20 mg/ml, 
Sigma), and digested with proteinase K (20 mg/ml, Amresco). Samples were briefly sonicated before 
analysis. FACS analysis was performed according to the manufacturer’s instructions (BD FACS Calibur). 
Data were analyzed using FlowJo software. (Fig. S14). 
 
synII Replication Timing Profiles Analysis 
Replication profiles were obtained using methods described previously (54). Asynchronous cells were fixed 
with 70% ethanol, treated with RNaseA and Proteinase K and stained with 10× Sytox. The MoFlo XDP was 
used to enrich for replicating and non-replicating cells. Sorted cells were treated with Zymolase, RNaseA and 
Proteinase K. DNA was purified using phenol-chloroform extraction and ethanol precipitation. Single end 
Illumina HiSeq2500 sequencing yielded a minimum of 29.6 million uniquely mapped reads per sample. The 
ratio between uniquely mapped reads from the non-replicating and the replicating sample were calculated for 
every 1000 bp window. The ratio was normalized to a baseline of one to control for differences in number of 
reads between the samples. 
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Fig. 1. Structure variation repair through chromosome breakage.  
(A) I-SceI mediated repair strategy for synII structure variations. The donor fragment was 
designed to carry a URA3 cassette (yellow) and I-SceI recognition site (red), with both ends 
overlapping the structural variation sequences observed in synII (yeast_chr02_9.01). The donor 
fragment was integrated into synII between the two tandem repeats through homologous 
recombination, then an episomal plasmid pRS413-pGal1-I-SceI was transformed into the cell. 
A double strand break at the I-SceI site was induced in galactose medium, and the homologous 
recombination of two partial chromosomes of synII eliminated the duplication.  
 (B) Structure variations in megachunks L and T and their corresponding donor sequence design. 
In megachunk L, a copy of chunk L2-L4 was observed following the original L2-L4 sequence 
that generated a tandem-duplication. The donor fragment was inserted directly between two 
duplications. In megachunk T, a complicated variation involving sequence of chunk T4-T5 was 
inserted into synII between chunk T4 and T5 and the donor fragment was inserted to remove the 
complex variation.  
 (C) Deep sequencing read depth analysis revealed the successful sequential removal of 
duplications. The starting synthetic chromosome synII (yeast_chr02_9.01) has both duplication 
regions, and after the first round of repair at megachunk L, the resulting chromosome synII 
(yeast_chr02_9.02) has only one duplication. The finished chromosome synII 
(yeast_chr02_9.03) was obtained after the second repair at the megachunk T region.   
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Fig. 2. Phenotypic profiling of synII.  
(A) Phenotype tests of synII on different media. 10-fold serial dilutions of overnight cultures of 
synII and wild-type (BY4741 and BY4742) strains were used for plating. From left to right: 
YPD at 25°C, 30°C, and 37°C; SC at 25°C, 30°C, and 37°C; low pH YPD (pH 4.0) and high 
pH YPD (pH 9.0); YPEG; SC+6-Azauracil; YPD+Benomyl; YPD+Camptothecin; 
YPD+Hydroxyurea; YPD+Cycloheximide (10 μg/ml, 2 hrs pretreatment); YPD+H2O2 (1 mM, 
2 hrs pretreatment); YPD+Sorbitol; YPD+MMS, (YPD, yeast extract peptone dextrose; YPEG, 
yeast extract peptone glycerol ethanol; MMS, methyl methane sulfone; SC, synthetic complete). 
 
(B) Growth curves of synIIA-R, synIIR-Y and synII strains compared with those of BY4741 and 
BY4742 strains in YPD at 30°C.  
 
(C) Cell cycle comparison between synII and BY4741. Images show cell morphology at 
different stages during the cell cycle after release from G1 block. DNA staining is shown in 
blue; CEN2-GFP in G1, S, G2 and M phase are shown in green. Graphs show the percentage of 
synII cells with separated CEN2-GFP dots, metaphase spindles and anaphase spindles during 
the cell cycle. For each time point at least 200 cells were counted. The inset numbers of 0.99 
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indicate the overall ratio of metaphase to anaphase cells throughout the time course for synII 
and BY4741 strains.  
(D) synII (red) and BY4741 (black) replication time expressed as relative copy number by deep 
sequencing. 
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Fig. 3. synII strain Trans-Omics profile (BY4741 as reference) demonstrates that the 
synthetic chromosome design has minimal impact on cell physiology, despite a modest up-
regulation of translational machinery triggered by tRNAs removal.  
 (A-D) Identified dysregulated genetic features at (A) transcriptome level, (B) proteome level 
and (C and D) metabolome level (Metabolic and lipid profiling in LC-MS positive mode 
respectively) of synII cells, compared to BY4741 cells. The detailed methods of these 
comparisons are described in the materials and methods section of the SOM. The total number 
of differentially expressed (p-value < 0.001) features in transcriptome, proteome and 
metabolome are also presented as well. Up-regulated and down-regulated features are labeled 
in red and green respectively. 
(E) Enriched pathways and the co-expression profile revealed by transcriptome and proteome 
in yeast GO terms. Up-regulated features are labeled in red and down-regulated features are 
labeled in green.  
(F) RNAseq analysis of synII with/without tRNA array. By adding back the tRNA array of 
synII, the up-regulation of translational functions is greatly mitigated. For E and F, significance 
level is indicated by heatmap color intensities and symbol sizes. Up-regulated and down-
regulated features are labeled in red and green respectively. 
 
 
 
 
